CXCL16 and neoplasm: These results suggested that GLUT1i may function in repressing Cxcl16 expression, which repolarizes the glyCAF towards a T-cell permissive non-glyCAF phenotype, which support CD8+ T cell trafficking into the inner tumor mass.